CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	6,256	2,588	1,243	4,456	18,571	13,464
Short-Term Investments	56,649	74,206	67,585	73,357	39,000	41,000
Trading Asset Securities	-	-	-	-	62,003	-
Cash & Short-Term Investments	62,905	76,794	68,827	77,813	119,574	54,464
Cash Growth	38.55%	11.58%	-11.55%	-34.92%	119.54%	-4.53%
Accounts Receivable	27,454	31,312	23,320	21,330	20,291	17,261
Other Receivables	1,615	1,174	929.56	1,143	869.89	445.57
Receivables	29,084	32,486	24,250	34,542	21,161	17,706
Inventory	33,858	23,788	20,570	21,270	9,049	8,573
Prepaid Expenses	1,437	141.95	150.35	143.3	71.04	43.16
Other Current Assets	1,384	1,649	1,940	1,301	729.16	583.76
Total Current Assets	128,668	134,859	115,737	135,070	150,584	81,370
Property, Plant & Equipment	90,880	77,977	50,711	37,472	24,119	17,269
Long-Term Investments	44,155	46,463	52,565	22,996	4,003	4,657
Goodwill	2,274	2,274	2,274	-	-	-
Other Intangible Assets	2,639	2,908	3,675	3,105	1,339	1,073
Long-Term Deferred Tax Assets	4,267	3,315	2,973	2,603	2,006	2,544
Long-Term Deferred Charges	17,406	16,372	13,627	11,282	9,736	6,999
Other Long-Term Assets	187.18	291.94	456.59	621.92	455.44	468.23
Total Assets	307,553	303,437	242,098	213,260	192,243	114,380
Accounts Payable	10,668	12,013	9,197	11,245	4,328	4,163
Accrued Expenses	2,797	3,198	3,204	2,917	2,054	1,378
Short-Term Debt	34,554	880	880	-	-	-
Current Portion of Long-Term Debt	25,000	-	-	-	-	-
Current Portion of Leases	177.26	221.4	206.16	356.41	129.64	-
Current Income Taxes Payable	-	-	-	99.45	-	19.86
Other Current Liabilities	21,844	15,145	11,042	7,285	2,794	2,935
Total Current Liabilities	95,041	31,457	24,529	21,903	9,306	8,495
Long-Term Debt	11,074	78,623	24,701	6,000	-	-
Long-Term Leases	191.1	240.26	332.07	356.43	156.76	-
Other Long-Term Liabilities	2,442	2,483	1,550	48.38	1,565	1,160
Total Liabilities	110,491	113,895	51,866	28,307	12,085	10,398
Common Stock	73,610	69,446	69,446	69,446	69,446	54,444
Additional Paid-In Capital	121,229	104,889	104,641	104,641	104,812	46,786
Retained Earnings	1,840	13,894	14,219	9,000	5,055	2,309
Comprehensive Income & Other	382.35	1,313	1,926	1,866	845.23	443.09
Shareholders' Equity	197,062	189,542	190,233	184,953	180,158	103,982
Total Liabilities & Equity	307,553	303,437	242,098	213,260	192,243	114,380
Total Debt	70,996	79,965	26,119	6,713	286.39	-
Net Cash (Debt)	-8,091	-3,171	42,708	71,100	119,288	54,464
Net Cash Growth	-	-	-39.93%	-40.40%	119.02%	-4.53%
Net Cash Per Share	-57.87	-20.18	307.49	511.91	981.40	500.19
Filing Date Shares Outstanding	147.22	138.89	138.89	138.89	138.89	108.89
Total Common Shares Outstanding	147.22	138.89	138.89	138.89	138.89	108.89
Working Capital	33,627	103,402	91,208	113,167	141,278	72,875
Book Value Per Share	1338.54	1364.67	1369.64	1331.63	1297.11	954.95
Tangible Book Value	192,149	184,360	184,284	181,848	178,820	102,909
Tangible Book Value Per Share	1305.17	1327.36	1326.81	1309.28	1287.47	945.10
Land	19,574	19,574	3,985	2,709	2,709	2,709
Buildings	12,312	12,312	11,004	10,741	10,741	10,741
Machinery	19,857	19,592	18,421	16,934	14,678	13,589
Construction In Progress	58,206	44,617	34,094	22,579	7,511	1,412

Source: S&P Global Market Intelligence. Standard template. Financial Sources.